| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2023 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.39B | 18.52B | 20.30B | 20.40B | 17.57B | 17.09B |
| Gross Profit | 6.77B | 7.35B | 8.15B | 8.57B | 7.61B | 7.91B |
| EBITDA | 4.62B | 9.61B | 17.02B | 5.88B | 6.45B | 4.86B |
| Net Income | 5.46B | 6.01B | 10.30B | 3.36B | 3.82B | 2.73B |
Balance Sheet | ||||||
| Total Assets | 82.29B | 80.29B | 78.70B | 64.53B | 57.59B | 56.69B |
| Cash, Cash Equivalents and Short-Term Investments | 7.60B | 16.07B | 18.02B | 16.25B | 13.00B | 13.91B |
| Total Debt | 19.40B | 22.05B | 21.83B | 18.92B | 11.58B | 13.72B |
| Total Liabilities | 24.16B | 26.43B | 29.11B | 22.18B | 14.93B | 15.98B |
| Stockholders Equity | 58.12B | 53.86B | 49.58B | 42.36B | 42.66B | 40.71B |
Cash Flow | ||||||
| Free Cash Flow | 992.52M | -117.58M | 2.24B | -97.74M | 2.64B | 4.44B |
| Operating Cash Flow | 3.61B | 1.89B | 4.97B | 3.75B | 3.21B | 5.46B |
| Investing Cash Flow | -3.63B | 1.19B | -5.58B | -8.09B | -506.70M | -4.68B |
| Financing Cash Flow | -6.39B | -1.64B | -492.22M | 3.76B | -3.94B | -1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥100.50B | 8.24 | ― | 2.30% | -0.22% | 25.09% | |
75 Outperform | ¥32.39B | 6.26 | ― | 4.33% | -1.31% | 67.27% | |
75 Outperform | ¥28.03B | 8.40 | ― | 3.52% | 6.15% | 17.51% | |
73 Outperform | ¥29.79B | 15.65 | ― | 5.04% | -2.29% | -41.92% | |
68 Neutral | ¥13.62B | 10.15 | ― | 3.42% | 8.37% | 8.13% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥2.99B | 18.61 | ― | 1.59% | -4.01% | -41.29% |